TIGIT and neoplasm: In the TIGIT signaling pathway network (TIGIT-NECTIN2 axis), tumor cells with a high CDI interacted with NK/T cells more significantly, which was conducive to tumor immunosuppression (Fig. 7I) (Ho et al. 2021; Sim et al. 2022).